Evaluation of Lungs of Normal Individuals by Lung Lavage, Brushing and Bronchial Wall Biopsy

Sponsor
Weill Medical College of Cornell University (Other)
Overall Status
Completed
CT.gov ID
NCT00224185
Collaborator
New York Presbyterian Hospital (Other), Rockefeller University (Other)
196
1
104
1.9

Study Details

Study Description

Brief Summary

The purpose of this study is to obtain biologic materials from the blood and lungs of normal individuals to establish a set of normal range for various parameters. These will provide important information when applied to individuals with various pulmonary diseases, and will help in understanding of the etiology and pathogenesis of various lung diseases.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Bronchopulmonary Lung Lavage
  • Procedure: Bronchial Brushing
  • Procedure: Bronchial Wall Biopsy

Detailed Description

Study procedures will be performed at the Weill Cornell Medical College-New York Presbyterian Hospital and/or Weill Greenburg York Avenue Building. Study procedures done elsewhere that are within the protocol timeframe will be accepted if seen fit by the investigators so that they are not repeated unnecessarily. Study individuals who undergo bronchoscopy with intravenous administration of sedatives and analgesia may be required to stay overnight. Bronchoscopy is normally an ambulatory procedure. The subject is observed after the bronchoscopy, including vital signs and level of consciousness, until they are back to baseline. An overnight stay would only be required if the individual was not, in the judgment of the attending physician, safe to be discharged as is standard practice. Follow up of all participants are carried out by telephone within 1 wk following the procedure.

Rockefeller University has been added as a second site.

Individuals undergoing bronchoscopy without intravenous administration of sedatives and analgesia are not required to stay overnight due to the lack of administration of CNS-altering drugs and the limited sampling involved (tracheal brushes only).

Study Design

Study Type:
Observational
Actual Enrollment :
196 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Evaluation of the Lungs of Normal Individuals With Segmental Bronchopulmonary Lung Lavage, Bronchial Brushing and Bronchial Wall Biopsy
Study Start Date :
Jan 1, 2004
Actual Primary Completion Date :
Sep 1, 2012
Actual Study Completion Date :
Sep 1, 2012

Outcome Measures

Primary Outcome Measures

  1. Evaluate etiology of lung diseases [9/31/2012]

    We hope to learn more about the specific causes of lung disease, how lung disease manifests and progresses, and how lung disease can be treated.

Secondary Outcome Measures

  1. Effect of smoking on the genes of airway epithelial cells [9/31/2012]

    We hope to learn how smoking affects the genetic composition of the cells that line the airways (windpipes) of the lungs, and whether there are differences in the genetic composition of the cells that line the windpipe in normal individuals who smoke.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All study subjects should be able to provide informed consent

  • Males or females ages 18 years and older.

  • Must provide HIV informed consent.

  • Non-smokers, ex-smokers and smokers.

Exclusion Criteria:
  • Individuals not deemed in good overall health by the investigator will not be accepted into the study.

  • Drug and/or alcohol abuse within the past six months.

  • Individuals with history of chronic lung disease, including asthma or with recurrent or recent (within three months) acute pulmonary disease will not be accepted into the study.

  • Individuals with allergies to atropine or any local anesthetic will not be accepted into the study.

  • Individuals with allergies to pilocarpine, isoproterenol, terbutaline, atropine or aminophylline will not be accepted into the study

  • Females who are pregnant or nursing will not be accepted into the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Genetic Medicine, WMC of Cornell Univeristy New York New York United States 10021

Sponsors and Collaborators

  • Weill Medical College of Cornell University
  • New York Presbyterian Hospital
  • Rockefeller University

Investigators

  • Principal Investigator: Ronald G Crystal, MD, Department of Genetic Medicine, Weill Cornell Medical College

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT00224185
Other Study ID Numbers:
  • IRB0005004439
  • NCT00234325
First Posted:
Sep 22, 2005
Last Update Posted:
May 2, 2016
Last Verified:
Apr 1, 2016
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Weill Medical College of Cornell University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 2, 2016